137 related articles for article (PubMed ID: 8069194)
1. Multiple myeloma: expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation.
Petersen AJ; Brown RD; Pope BB; Jamieson GP; Paterson AR; Gibson J; Wiley JS; Joshua DE
Leuk Lymphoma; 1994 May; 13(5-6):491-9. PubMed ID: 8069194
[TBL] [Abstract][Full Text] [Related]
2. The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state.
Pope B; Brown RD; Gibson J; Petersen A; Wiley J; Joshua DE
Leuk Lymphoma; 1997 Sep; 27(1-2):83-91. PubMed ID: 9373199
[TBL] [Abstract][Full Text] [Related]
3. Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter.
Wiley JS; Cebon JS; Jamieson GP; Szer J; Gibson J; Woodruff RK; McKendrick JJ; Sheridan WP; Biggs JC; Snook MB
Leukemia; 1994 Jan; 8(1):181-5. PubMed ID: 8289485
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
Hata H; Matsuzaki H; Matsuno F; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
Clin Exp Immunol; 1994 May; 96(2):370-5. PubMed ID: 8187346
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma: relationship between light chain isotype suppression, labelling index of plasma cells, and CD38 expression on peripheral blood lymphocytes.
Joshua DE; Ioannidis R; Brown R; Francis SE; Gibson J; Kronenberg H
Am J Hematol; 1988 Sep; 29(1):5-11. PubMed ID: 3052044
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric quantitation of nucleoside transporter sites on human leukemic cells.
Jamieson GP; Brocklebank AM; Snook MB; Sawyer WH; Buolamwini JK; Paterson AR; Wiley JS
Cytometry; 1993; 14(1):32-8. PubMed ID: 8432200
[TBL] [Abstract][Full Text] [Related]
7. Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells.
Yi Q; Dabadghao S; Osterborg A; Bergenbrant S; Holm G
Blood; 1997 Sep; 90(5):1960-7. PubMed ID: 9292530
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry.
Terstappen LW; Johnsen S; Segers-Nolten IM; Loken MR
Blood; 1990 Nov; 76(9):1739-47. PubMed ID: 2224123
[TBL] [Abstract][Full Text] [Related]
9. Expression of beta 1 integrins (very late antigens-4 and -5) on myeloma cells and clinical correlates in patients with multiple myeloma.
Nishinarita S; Shimada H; Ito T; Namiki H; Kawahira H; Sawada U; Horie T
J Int Med Res; 1998; 26(1):37-42. PubMed ID: 9513075
[TBL] [Abstract][Full Text] [Related]
10. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
11. Identification of immature and mature myeloma cells in the bone marrow of human myelomas.
Kawano MM; Huang N; Harada H; Harada Y; Sakai A; Tanaka H; Iwato K; Kuramoto A
Blood; 1993 Jul; 82(2):564-70. PubMed ID: 8329711
[TBL] [Abstract][Full Text] [Related]
12. Leu-19 in myeloma--a new role for an old antibody.
Wetter O; Brandhorst D; Reiter W
Eur J Cancer; 1990 Apr; 26(4):541. PubMed ID: 1694090
[No Abstract] [Full Text] [Related]
13. Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells.
Tsujimoto T; Lisukov IA; Huang N; Mahmoud MS; Kawano MM
Blood; 1996 Apr; 87(8):3375-83. PubMed ID: 8605355
[TBL] [Abstract][Full Text] [Related]
14. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D; Ahmann G; Greipp P; Van Ness B
J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
[TBL] [Abstract][Full Text] [Related]
15. [Detection of myeloma cells in peripheral blood using multi-parameter flow cytometry: monitoring residual disease].
Klabusay M; Doubek M; Adam Z; Hájek R; Krivanová A
Cas Lek Cesk; 2000 Jul; 139(14):432-6. PubMed ID: 11048405
[TBL] [Abstract][Full Text] [Related]
16. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.
Leo R; Boeker M; Peest D; Hein R; Bartl R; Gessner JE; Selbach J; Wacker G; Deicher H
Ann Hematol; 1992 Mar; 64(3):132-9. PubMed ID: 1373957
[TBL] [Abstract][Full Text] [Related]
17. The bone marrow plasma cell labeling index by flow cytometry.
Pope B; Brown R; Gibson J; Joshua D
Cytometry; 1999 Dec; 38(6):286-92. PubMed ID: 10589044
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of CD38 as target for immunotherapy in multiple myeloma.
Vooijs WC; Schuurman HJ; Bast EJ; de Gast GC
Blood; 1995 Apr; 85(8):2282-4. PubMed ID: 7718903
[No Abstract] [Full Text] [Related]
19. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
Ak I; Aslan V; Vardareli E; Gülbaş Z
Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]